Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege

Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege

Item
http://www.wikidata.org/entity/Q33997713
Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancerThe cancer stem cell: evidence for its origin as an injured autoreactive T cellMatrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosisInverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack.TRAIL protein expression in breast cancer cells correlates with nuclear gradeNewly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo.Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.Prognostic value of the Fas/Fas ligand system in breast cancer.Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines.Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFα and NO-dependent mechanism, promoting a tumor-supportive environment.
P2860

Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege

Item
http://www.wikidata.org/entity/Q33997713
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Expression of Fas (CD95/APO-1) ...... nce for tumor immune privilege
@ast
Expression of Fas (CD95/APO-1) ...... nce for tumor immune privilege
@en
type
label
Expression of Fas (CD95/APO-1) ...... nce for tumor immune privilege
@ast
Expression of Fas (CD95/APO-1) ...... nce for tumor immune privilege
@en
prefLabel
Expression of Fas (CD95/APO-1) ...... nce for tumor immune privilege
@ast
Expression of Fas (CD95/APO-1) ...... nce for tumor immune privilege
@en
P1433
P1476
P2093
P2860
P304
P31
P433
P478
P577
P698
P932
P1433
P1476
Expression of Fas (CD95/APO-1) ...... nce for tumor immune privilege
@en
P2093
P2860
P304
P31
P433
P478
P577
P698
P932